The Medical Research Council (MRC) is ‘a good egg’ and that’s the issue

Science historian and Guardian science blogger, Vanessa Heggie (@HPS_Vanessa) has written a fascinating piece about how AIDS activists among others changed the way we run clinical trials and persuaded researchers to adopt new methods. That’s certainly the history lesson passed down to me as Chair of INVOLVE by previous members.  They will tell you that, before we ever talked […]

INVOLVE steps forward to change behaviours on plain English summaries of health research

I make no apology for being a little bit obsessed by plain English summaries of research this week.  Events have conspired to make it this way. So, what did NIHR do when faced late last year with rising concern among academics, researchers, patients and the public about the poor quality of lay summaries?  It commissioned […]

Science interviews: Tooke goes collaborative, and Glover is not overcome by emotion

I thought the following interviews might be of general interest.  Both are with recently appointed science leaders.  Both, among other things, major on the need for greater collaboration in research. Times Higher Educational Supplement (THES) interviews the new President of the Academy of Medical Sciences, Sir John Tooke. Sir John chaired the discussion panel I was […]

Social media and medical research, a story from Oz

I am in international mood today.  From the United States to Australia.  Unfortunately not via Hawaii. This was sent to me this morning and it’s basically a report of a paper appearing in the Journal of Internet Medical Research about the viability of using social media in medical research. Interesting snapshot discussion around the pitfalls – i.e. […]

Ill-informed consent: EU meeting lays into clinical trials small print for patients

Image by erjkprunczyk via Flickr Daniel Cressey at Nature has written this report from last week’s meeting of the European Forum for Good Clinical Practice which took place in Brussels. The basic thrust of the discussion at the meeting was that information given to patients prior to them signing up for a clinical trial: is often vague, too […]